[Remote] Director, SOX at Clairo

United States

Apply Now

$150,000 – $220,000Compensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Financial Services, SoftwareIndustries

Requirements

Bachelor’s degree in Accounting, Finance, Business Administration, or related field
12+ years of progressive experience in SOX compliance, internal controls, or risk management
At least 5 years in a leadership role managing teams and programs
Proven expertise in SOX 404, PCAOB standards, and COSO framework
Strong proficiency in project management and cross-functional coordination
Demonstrated ability to influence and communicate across all levels, including executive leadership
CPA, CIA, or CISA designation strongly preferred
Experience in public company environments; IPO readiness is a plus
Exposure to both Finance and IT control environments
Based in or able to work from the United States (remote/hybrid/on-site)

Responsibilities

Develop, implement, and oversee Clario’s SOX compliance strategy and program
Establish and maintain a comprehensive SOX framework aligned with regulatory requirements and best practices
Partner with Finance, IT, and business process owners to design and implement effective internal controls
Drive remediation plans for control deficiencies and monitor resolution progress
Coordinate risk assessments to address evolving business processes and systems
Provide regular updates to executive leadership and the Audit Committee
Maintain audit-ready documentation including control matrices, narratives, and testing results
Serve as primary liaison with external auditors for management testing
Build strong relationships across the organization to embed SOX ownership
Recruit, mentor, and lead a high-performing SOX compliance team

Skills

SOX Compliance

Internal Controls

Risk Management

SOX 404

PCAOB

COSO Framework

Project Management

Cross-functional Coordination

Leadership

Team Management

Audit

Compliance

Governance

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free